Company · CIK 0000784199 · SIC 3841 — Surgical & Medical Instruments & Apparatus · NYSE
ARTIVION, INC. · AORT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 SForm 4 → | Sep 11, 5:28 pm EDT | Andrew M GreenSVP, Regulatory and Quality | 11,480 | $24.97 | $286,656 | 40,160 | −22.2% | |
| Sep 2, 2026 SForm 4 → | Sep 4, 2:15 pm EDT | Andrew M GreenSVP, Regulatory and Quality | 8,003 | $27.03 | $216,337 | 51,640 | −13.4% | |
| Aug 19, 2026 SForm 4 → | Aug 20, 2:11 pm EDT | James P MackinPresident & CEO | 70,000 | $28.96 | $2,026,850 | 877,275 | −7.39% | |
| Aug 14, 2026 SForm 4 → | Aug 17, 3:18 pm EDT | Andrew M GreenSVP, Regulatory and Quality | 616 | $28.55 | $17,586 | 59,643 | −1.02% | |
| Aug 14, 2026 SForm 4 → | Aug 17, 3:17 pm EDT | Lance A BerryEVP, COO, CFO & Treasurer | 715 | $28.55 | $20,413 | 210,112 | −0.34% | |
| Aug 12, 2026 SForm 4 → | Aug 12, 5:51 pm EDT | Jean F HollowaySVP, General Counsel | 977 | $28.49 | $27,835 | 184,118 | −0.53% | |
| Jun 11, 2026 SForm 4 → | Jun 15, 11:28 am EDT | Andrew M GreenSVP, Regulatory and Quality | 44,001 | $20.70 | $910,739 | 60,259 | −42.2% | 10b5-1 |
| Jun 11, 2026 MForm 4 → | Jun 15, 11:28 am EDT | Andrew M GreenSVP, Regulatory and Quality | 44,001 | $13.39 | $589,078 | 90,259 | — | 10b5-1 |
| Jun 2, 2026 JForm 4 → | Jun 4, 4:50 pm EDT | Anthony B. SemedoDirector | 12,650 | — | — | 6,325 | — | |
| Mar 6, 2019 SForm 4 → | Mar 8, 6:10 pm EST | Amy HortonVP, Chief Accounting Officer | 6,666 | $29.15 | $194,299 | 97,047 | −6.43% | plan? |
| Mar 6, 2019 MForm 4 → | Mar 8, 6:10 pm EST | Amy HortonVP, Chief Accounting Officer | 6,666 | $6.12 | $40,796 | 103,713 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 8, 10:23 am EST | Thomas J BogenschuetzVP, EMEA & General Manager | 4,952 | — | — | 18,258 | — | plan? late |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:56 pm EST | Scott B CappsVP, Clinical Research | 2,813 | — | — | 140,455 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:55 pm EST | John E DavisSenior VP, Global Sales | 4,952 | — | — | 49,757 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:53 pm EST | Jean F HollowayVP, General Counsel | 4,952 | — | — | 53,323 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:52 pm EST | Amy HortonVP, Chief Accounting Officer | 3,095 | — | — | 97,047 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:51 pm EST | David Ashley LeeExecutive VP, COO & CFO | 5,908 | — | — | 278,469 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:49 pm EST | James P MackinPresident & CEO | 23,948 | — | — | 252,541 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:48 pm EST | Dennis B MaierVice President, Operations | 2,813 | — | — | 11,943 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:45 pm EST | James M McDermidSVP, CHRO | 4,501 | — | — | 26,603 | — | plan? |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:43 pm EST | Michael S SimpsonSVP, Regulatory Affairs and QA | 4,501 | — | — | 15,523 | — | plan? |
| Mar 2, 2019 FForm 4 → | Mar 7, 9:44 pm EST | Sherry M SauriniVP, Quality | 1,388 | $29.70 | $41,224 | 22,460 | — | plan? late |
| Mar 1, 2019 FForm 4 → | Mar 4, 8:26 am EST | Sherry M SauriniVP, Quality | 778 | $29.70 | $23,107 | 23,848 | — | plan? |
| Mar 1, 2019 FForm 4 → | Mar 4, 8:22 am EST | James M McDermidSVP, CHRO | 501 | $29.70 | $14,880 | 22,102 | — | plan? |
| Mar 1, 2019 FForm 4 → | Mar 4, 8:19 am EST | James P MackinPresident & CEO | 8,103 | $29.70 | $240,659 | 228,593 | — | plan? |
| Mar 1, 2019 FForm 4 → | Mar 4, 8:17 am EST | David Ashley LeeExecutive VP, COO & CFO | 2,015 | $29.70 | $59,846 | 272,561 | — | plan? |
| Mar 1, 2019 FForm 4 → | Mar 4, 8:13 am EST | Amy HortonVP, Chief Accounting Officer | 1,133 | $29.70 | $33,650 | 93,952 | — | plan? |
| Mar 1, 2019 FForm 4 → | Mar 4, 8:08 am EST | Jean F HollowayVP, General Counsel | 1,506 | $29.70 | $44,728 | 48,371 | — | plan? |
| Mar 1, 2019 FForm 4 → | Mar 4, 8:05 am EST | John E DavisSenior VP, Global Sales | 1,485 | $29.70 | $44,105 | 44,805 | — | plan? |
| Mar 1, 2019 FForm 4 → | Mar 4, 8:03 am EST | Scott B CappsVP, Clinical Research | 1,087 | $29.70 | $32,284 | 137,642 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 7:53 pm EST | David Ashley LeeExecutive VP, COO & CFO | 1,103 | $29.38 | $32,406 | 274,576 | — | plan? |
| Feb 22, 2019 FForm 4 → | Feb 25, 7:51 pm EST | Jean F HollowayVP, General Counsel | 882 | $29.38 | $25,913 | 49,877 | — | plan? |
| Feb 21, 2019 SForm 4 → | Feb 25, 7:52 pm EST | Ronald D McCallDirector | 6,200 | $29.26 | $181,390 | 137,699 | −4.31% | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:30 pm EST | Sherry M SauriniVP, Quality | 1,760 | $28.84 | $50,758 | 24,626 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:29 pm EST | Amy HortonVP, Chief Accounting Officer | 2,368 | $28.84 | $68,293 | 95,085 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:28 pm EST | Scott B CappsVP, Clinical Research | 2,358 | $28.84 | $68,005 | 138,729 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:27 pm EST | John E DavisSenior VP, Global Sales | 2,941 | $28.84 | $84,818 | 46,290 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:26 pm EST | Jean F HollowayVP, General Counsel | 2,933 | $28.84 | $84,588 | 50,759 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:25 pm EST | David Ashley LeeExecutive VP, COO & CFO | 4,053 | $28.84 | $116,889 | 275,679 | — | plan? |
| Feb 19, 2019 FForm 4 → | Feb 21, 5:24 pm EST | James P MackinPresident & CEO | 6,602 | $28.84 | $190,402 | 236,696 | — | plan? |
| Dec 31, 2018 MForm 5 → | Feb 19, 2019, 7:48 am EST | Sherry M SauriniVP, Quality | 113 | $23.67 | $2,675 | 26,386 | — | plan? |
| Dec 31, 2018 MForm 5 → | Feb 19, 2019, 7:47 am EST | James M McDermidSVP, CHRO | 89 | $23.67 | $2,107 | 22,603 | — | plan? |
| Dec 31, 2018 MForm 5 → | Feb 19, 2019, 7:46 am EST | Jean F HollowayVP, General Counsel | 307 | $23.67 | $7,267 | 53,692 | — | plan? |
| Sep 18, 2018 SForm 4 → | Sep 20, 5:02 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $33.86 | $112,843 | 49,231 | −6.34% | plan? |
| Sep 18, 2018 MForm 4 → | Sep 20, 5:02 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $9.64 | $32,130 | 52,564 | — | plan? |
| Sep 10, 2018 FForm 4 → | Sep 12, 4:51 pm EDT | Jean F HollowayVP, General Counsel | 2,201 | $34.00 | $74,834 | 53,385 | — | plan? |
| Sep 10, 2018 FForm 4 → | Sep 12, 4:50 pm EDT | John E DavisSenior VP, Global Sales | 3,512 | $34.00 | $119,408 | 49,231 | — | plan? |
| Sep 5, 2018 SForm 4 → | Sep 6, 4:21 pm EDT | C Elkins RonaldDirector | 5,000 | $34.53 | $172,672 | 64,843 | −7.16% | plan? |
| Aug 30, 2018 SForm 4 → | Sep 4, 6:59 pm EDT | Scott B CappsVP, Clinical Research | 6,332 | $34.10 | $215,921 | 141,087 | −4.30% | plan? |
| Aug 30, 2018 MForm 4 → | Sep 4, 6:59 pm EDT | Scott B CappsVP, Clinical Research | 8,332 | $5.67 | $47,242 | 147,419 | — | plan? |
| Aug 28, 2018 JForm 4 → | Aug 29, 4:54 pm EDT | James P MackinPresident & CEO | 34,600 | — | — | 243,298 | — | plan? |
| Aug 17, 2018 GForm 4 → | Aug 21, 9:26 am EDT | Jean F HollowayVP, General Counsel | 3,149 | — | — | 55,586 | — | plan? |
| Aug 15, 2018 SForm 4 → | Aug 16, 5:24 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 16,666 | $31.92 | $531,994 | 279,732 | −5.62% | plan? |
| Aug 15, 2018 MForm 4 → | Aug 16, 5:24 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 16,666 | $5.67 | $94,496 | 296,398 | — | plan? |
| Aug 13, 2018 SForm 4 → | Aug 15, 5:49 pm EDT | Harvey MorganDirector | 10,000 | $32.54 | $325,433 | 38,298 | −20.7% | plan? |
| Aug 13, 2018 SForm 4 → | Aug 15, 5:48 pm EDT | James P MackinPresident & CEO | 150,000 | $32.16 | $4,823,631 | 277,898 | −35.1% | plan? |
| Aug 13, 2018 MForm 4 → | Aug 15, 5:48 pm EDT | James P MackinPresident & CEO | 150,000 | $10.24 | $1,536,000 | 287,749 | — | plan? |
| Aug 10, 2018 SForm 4 → | Aug 13, 4:43 pm EDT | James P MackinPresident & CEO | 42,675 | $33.32 | $1,421,969 | 277,898 | −13.3% | plan? |
| Aug 10, 2018 SForm 4 → | Aug 13, 4:37 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 10,247 | $32.98 | $337,924 | 279,732 | −3.53% | plan? |
| Aug 10, 2018 SForm 4 → | Aug 13, 4:35 pm EDT | Amy HortonVP, Chief Accounting Officer | 3,000 | $32.85 | $98,550 | 97,453 | −2.99% | plan? |
| Aug 10, 2018 SForm 4 → | Aug 13, 4:34 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $33.50 | $50,250 | 58,735 | −2.49% | plan? |
| Aug 10, 2018 MForm 4 → | Aug 13, 4:34 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $10.28 | $15,420 | 60,235 | — | plan? |
| Aug 10, 2018 SForm 4 → | Aug 13, 4:31 pm EDT | C Elkins RonaldDirector | 1,154 | $33.27 | $38,393 | 69,843 | −1.63% | plan? |
| Aug 9, 2018 AForm 4 → | Aug 15, 5:47 pm EDT | Marna P BorgstromDirector | 3,456 | — | — | 3,456 | — | plan? late |
| Aug 9, 2018 SForm 4 → | Aug 13, 4:39 pm EDT | Ronald D McCallDirector | 2,750 | $32.69 | $89,900 | 143,899 | −1.88% | plan? |
| Aug 9, 2018 JForm 4 → | Aug 9, 5:26 pm EDT | James P MackinPresident & CEO | 30,522 | — | — | 320,573 | — | plan? |
| Aug 7, 2018 SForm 4 → | Aug 9, 5:27 pm EDT | Jean F HollowayVP, General Counsel | 4,000 | $32.50 | $130,000 | 58,735 | −6.38% | plan? |
| Aug 7, 2018 MForm 4 → | Aug 9, 5:27 pm EDT | Jean F HollowayVP, General Counsel | 4,000 | $10.28 | $41,120 | 62,735 | — | plan? |
| Jul 26, 2018 SForm 4 → | Jul 30, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 3,391 | $31.00 | $105,121 | 52,743 | −6.04% | plan? |
| Jul 26, 2018 MForm 4 → | Jul 30, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 3,391 | $16.30 | $55,273 | 56,134 | — | plan? |
| Jul 23, 2018 SForm 4 → | Jul 25, 4:44 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $30.50 | $45,750 | 58,735 | −2.49% | plan? |
| Jul 23, 2018 MForm 4 → | Jul 25, 4:44 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $10.28 | $15,420 | 60,235 | — | plan? |
| Jul 6, 2018 SForm 4 → | Jul 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 3,391 | $30.00 | $101,730 | 52,746 | −6.04% | plan? |
| Jun 14, 2018 DMForm 4 → | Jun 15, 5:19 pm EDT | John E DavisSenior VP, Global Sales | 8,744 | $19.62 | $171,557 | 51,438 | — | plan? |
| Jun 14, 2018 SForm 4 → | Jun 15, 5:17 pm EDT | C Elkins RonaldDirector | 5,000 | $28.89 | $144,447 | 70,997 | −6.58% | plan? |
| Jun 1, 2018 SForm 4 → | Jun 5, 4:23 pm EDT | Amy HortonVP, Chief Accounting Officer | 2,256 | $28.00 | $63,168 | 100,453 | −2.20% | plan? |
| Jun 1, 2018 MForm 4 → | Jun 5, 4:23 pm EDT | Amy HortonVP, Chief Accounting Officer | 5,000 | $5.67 | $28,350 | 102,709 | — | plan? |
| Jun 1, 2018 SForm 4 → | Jun 5, 4:22 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $28.00 | $122,444 | 51,438 | −7.84% | plan? |
| Jun 1, 2018 MForm 4 → | Jun 5, 4:22 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 55,811 | — | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 9:07 am EDT | C Elkins RonaldDirector | 3,000 | $27.18 | $81,525 | 75,997 | −3.80% | plan? |
| May 23, 2018 AForm 4 → | May 25, 5:22 pm EDT | Jon W SalvesonDirector | 4,638 | — | — | 83,987 | — | plan? |
| May 23, 2018 AForm 4 → | May 25, 5:21 pm EDT | Harvey MorganDirector | 4,638 | — | — | 50,570 | — | plan? |
| May 23, 2018 AForm 4 → | May 25, 5:19 pm EDT | Ronald D McCallDirector | 4,638 | — | — | 146,649 | — | plan? |
| May 23, 2018 AForm 4 → | May 25, 5:17 pm EDT | Jeffrey H BurbankDirector | 4,638 | — | — | 8,164 | — | plan? |
| May 23, 2018 AForm 4 → | May 25, 5:15 pm EDT | James BullockDirector | 4,638 | — | — | 12,904 | — | plan? |
| May 23, 2018 AForm 4 → | May 25, 5:14 pm EDT | Daniel J BevevinoDirector | 4,638 | — | — | 103,987 | — | plan? |
| May 23, 2018 AForm 4 → | May 25, 5:12 pm EDT | Thomas F AckermanDirector | 4,638 | — | — | 103,987 | — | plan? |
| May 16, 2018 SForm 4 → | May 18, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $27.00 | $118,071 | 51,438 | −7.84% | plan? |
| May 16, 2018 MForm 4 → | May 18, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 55,811 | — | plan? |
| May 14, 2018 SForm 4 → | May 15, 5:32 pm EDT | C Elkins RonaldDirector | 10,000 | $24.75 | $247,500 | 78,997 | −11.2% | plan? |
| May 10, 2018 GForm 4 → | May 11, 5:21 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 100 | $25.30 | $2,530 | 289,979 | — | plan? |
| May 9, 2018 SForm 4 → | May 11, 5:23 pm EDT | Ronald D McCallDirector | 4,240 | $25.54 | $108,276 | 142,271 | −2.89% | plan? |
| May 9, 2018 SForm 4 → | May 11, 5:21 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 10,000 | $25.70 | $256,999 | 290,079 | −3.33% | plan? |
| May 9, 2018 GForm 4 → | May 11, 5:20 pm EDT | Amy HortonVP, Chief Accounting Officer | 1,250 | $25.45 | $31,813 | 97,709 | — | plan? |
| May 9, 2018 SForm 4 → | May 11, 5:20 pm EDT | Amy HortonVP, Chief Accounting Officer | 4,000 | $25.94 | $103,764 | 98,959 | −3.89% | plan? |
| May 8, 2018 SForm 4 → | May 15, 5:30 pm EDT | Ronald D McCallDirector | 260 | $25.95 | $6,747 | 142,011 | −0.18% | plan? late |
| May 8, 2018 SForm 4 → | May 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $26.00 | $113,698 | 51,438 | −7.84% | plan? |
| May 8, 2018 MForm 4 → | May 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 55,811 | — | plan? |
| May 8, 2018 SForm 4 → | May 10, 4:41 pm EDT | C Elkins RonaldDirector | 6,852 | $25.38 | $173,879 | 88,997 | −7.15% | plan? |
| May 3, 2018 SForm 4 → | May 8, 4:26 pm EDT | C Elkins RonaldDirector | 2,000 | $24.00 | $48,000 | 95,849 | −2.04% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 MForm 4 → | Jun 15, 11:28 am EDT | Andrew M GreenSVP, Regulatory and Quality | 44,001 | — | — | 0 | — | 10b5-1 |
| Mar 6, 2019 MForm 4 → | Mar 8, 6:10 pm EST | Amy HortonVP, Chief Accounting Officer | 6,666 | $6.12 | $40,796 | 0 | — | |
| Mar 5, 2019 AForm 4 → | Mar 8, 10:23 am EST | Thomas J BogenschuetzVP, EMEA & General Manager | 12,787 | — | — | 12,787 | — | late |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:56 pm EST | Scott B CappsVP, Clinical Research | 7,265 | — | — | 7,265 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:55 pm EST | John E DavisSenior VP, Global Sales | 12,787 | — | — | 12,787 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:53 pm EST | Jean F HollowayVP, General Counsel | 12,787 | — | — | 12,787 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:52 pm EST | Amy HortonVP, Chief Accounting Officer | 7,992 | — | — | 7,992 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:51 pm EST | David Ashley LeeExecutive VP, COO & CFO | 15,257 | — | — | 15,257 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:49 pm EST | James P MackinPresident & CEO | 61,842 | — | — | 61,842 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:48 pm EST | Dennis B MaierVice President, Operations | 7,265 | — | — | 7,265 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:45 pm EST | James M McDermidSVP, CHRO | 11,625 | — | — | 11,625 | — | |
| Mar 5, 2019 AForm 4 → | Mar 7, 9:43 pm EST | Michael S SimpsonSVP, Regulatory Affairs and QA | 11,625 | — | — | 11,625 | — | |
| Sep 18, 2018 MForm 4 → | Sep 20, 5:02 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $9.64 | $32,130 | 0 | — | |
| Aug 30, 2018 MForm 4 → | Sep 4, 6:59 pm EDT | Scott B CappsVP, Clinical Research | 8,332 | $5.67 | $47,242 | 0 | — | |
| Aug 15, 2018 MForm 4 → | Aug 16, 5:24 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 16,666 | $5.67 | $94,496 | 0 | — | |
| Aug 13, 2018 MForm 4 → | Aug 15, 5:48 pm EDT | James P MackinPresident & CEO | 150,000 | $10.24 | $1,536,000 | 16,265 | — | |
| Aug 10, 2018 MForm 4 → | Aug 13, 4:34 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $10.28 | $15,420 | 0 | — | |
| Aug 7, 2018 MForm 4 → | Aug 9, 5:27 pm EDT | Jean F HollowayVP, General Counsel | 4,000 | $10.28 | $41,120 | 1,500 | — | |
| Aug 7, 2018 JForm 4 → | Aug 9, 5:26 pm EDT | James P MackinPresident & CEO | 331,300 | — | — | 75,615 | — | |
| Jul 26, 2018 MForm 4 → | Jul 30, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 3,391 | $16.30 | $55,273 | 0 | — | |
| Jul 23, 2018 MForm 4 → | Jul 25, 4:44 pm EDT | Jean F HollowayVP, General Counsel | 1,500 | $10.28 | $15,420 | 5,500 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:48 am EST | Sherry M SauriniVP, Quality | 226 | $23.67 | $5,350 | 0 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:47 am EST | James M McDermidSVP, CHRO | 178 | $23.67 | $4,214 | 0 | — | |
| Jul 1, 2018 AMForm 5 → | Feb 19, 2019, 7:46 am EST | Jean F HollowayVP, General Counsel | 614 | $23.67 | $14,535 | 0 | — | |
| Jun 14, 2018 MForm 4 → | Jun 15, 5:19 pm EDT | John E DavisSenior VP, Global Sales | 4,372 | $10.24 | $44,769 | 8,745 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 4:23 pm EDT | Amy HortonVP, Chief Accounting Officer | 5,000 | $5.67 | $28,350 | 0 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 4:22 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 13,117 | — | |
| May 16, 2018 DForm 4 → | May 18, 4:32 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $27.00 | $118,071 | 17,490 | — | |
| May 8, 2018 MForm 4 → | May 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 4,373 | $10.24 | $44,780 | 17,491 | — | |
| May 3, 2018 MForm 4 → | May 8, 4:24 pm EDT | John E DavisSenior VP, Global Sales | 3,334 | $9.64 | $32,140 | 3,333 | — | late |
| Apr 17, 2018 MForm 4 → | Apr 18, 4:42 pm EDT | John E DavisSenior VP, Global Sales | 3,333 | $9.64 | $32,130 | 6,667 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:52 pm EDT | James M McDermidSVP, CHRO | 15,910 | — | — | 15,910 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:51 pm EDT | James P MackinPresident & CEO | 77,562 | — | — | 77,562 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:50 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 21,877 | — | — | 21,877 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:50 pm EDT | Amy HortonVP, Chief Accounting Officer | 12,430 | — | — | 12,430 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:49 pm EDT | Jean F HollowayVP, General Counsel | 19,092 | — | — | 19,092 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:48 pm EDT | John E DavisSenior VP, Global Sales | 15,910 | — | — | 15,910 | — | |
| Mar 12, 2018 AForm 4 → | Mar 14, 7:47 pm EDT | Scott B CappsVP, Clinical Research | 9,944 | — | — | 9,944 | — | |
| Feb 13, 2018 MForm 4 → | Feb 15, 5:28 pm EST | Scott B CappsVP, Clinical Research | 31,333 | $17.10 | $535,794 | 0 | — | |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:49 pm EDT | Sherry M SauriniVP, Quality | 382 | $16.24 | $6,202 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:47 pm EDT | James M McDermidSVP, CHRO | 2,358 | $16.24 | $38,282 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:46 pm EDT | Jean F HollowayVP, General Counsel | 1,722 | $16.24 | $27,957 | 0 | — | late |
| Jan 1, 2018 AMForm 4 → | Jul 10, 4:43 pm EDT | John E DavisSenior VP, Global Sales | 6,007 | $16.27 | $97,744 | 16,953 | — | late |
| Dec 31, 2017 AMForm 5 → | Jan 25, 2018, 4:47 pm EST | James M McDermidSVP, CHRO | 1,642 | $16.28 | $26,728 | 0 | — | |
| Dec 31, 2017 AMForm 5 → | Jan 25, 2018, 4:46 pm EST | Jean F HollowayVP, General Counsel | 1,134 | $16.28 | $18,459 | 0 | — | |
| Nov 16, 2017 MForm 4 → | Nov 17, 4:17 pm EST | David C GaleVP, Research & Development | 20,000 | — | — | 0 | — | |
| Nov 8, 2017 MForm 4 → | Nov 13, 4:47 pm EST | David Ashley LeeExecutive VP, COO & CFO | 63,333 | $18.80 | $1,190,438 | 0 | — | late |
| Jun 27, 2017 MForm 4 → | Jun 29, 9:19 am EDT | Amy HortonVP, Chief Accounting Officer | 18,667 | — | — | 0 | — | |
| Feb 22, 2017 MForm 4 → | Feb 24, 9:10 am EST | Scott B CappsVP, Clinical Research | 16,667 | $16.40 | $273,360 | 0 | — | |
| Dec 31, 2016 AMForm 5 → | Jul 11, 2017, 8:56 am EDT | John E DavisSenior VP, Global Sales | 6,610 | — | — | 0 | — | |
| Sep 12, 2016 MForm 4 → | Sep 14, 5:30 pm EDT | Jean F HollowayVP, General Counsel | 3,000 | — | — | 3,000 | — | |
| Sep 12, 2016 MForm 4 → | Sep 14, 5:21 pm EDT | David C GaleVP, Research & Development | 3,000 | — | — | 3,000 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 6:07 pm EDT | David Ashley LeeExecutive VP, COO & CFO | 33,333 | — | — | 1,500 | — | |
| Jul 26, 2016 MForm 4 → | Jul 28, 4:34 pm EDT | Amy HortonVP, Chief Accounting Officer | 10,000 | — | — | 0 | — | |
| Jun 30, 2016 AMForm 5 → | Jul 11, 2017, 8:58 am EDT | Jean F HollowayVP, General Counsel | 5,838 | — | — | 0 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:47 pm EST | Sherry M SauriniVP, Quality | 14,913 | — | — | 14,913 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:45 pm EST | William Robert MatthewsSenior VP, Operations, Quality | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:44 pm EST | James P MackinPresident & CEO | 119,672 | — | — | 119,672 | — | amended |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:43 pm EST | David Ashley LeeExecutive VP, COO & CFO | 36,822 | — | — | 36,822 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:41 pm EST | Amy HortonVP, Chief Accounting Officer | 20,713 | — | — | 20,713 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:39 pm EST | Jean F HollowayVP, General Counsel | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:37 pm EST | David C GaleVP, Research & Development | 20,713 | — | — | 20,713 | — | |
| Feb 19, 2016 AForm 4 → | Feb 23, 5:36 pm EST | John E DavisSenior VP, Global Sales | 26,236 | — | — | 26,236 | — | |
| Feb 19, 2016 AMForm 4 → | Feb 23, 5:35 pm EST | Scott B CappsVP, Clinical Research | 35,713 | — | — | 418 | — | |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:36 pm EST | Amy HortonVP, Chief Accounting Officer | 9,000 | — | — | 9,000 | — | |
| Feb 17, 2016 MForm 4 → | Feb 19, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 20,700 | — | — | 8,000 | — | |
| Dec 28, 2015 MForm 4 → | Dec 30, 3:25 pm EST | David Ashley LeeExec. VP, COO and CFO | 1,000 | — | — | 8,200 | — | |
| Nov 27, 2015 MForm 4 → | Dec 1, 4:35 pm EST | David Ashley LeeExecutive VP, COO & CFO | 15,800 | — | — | 8,500 | — | |
| Sep 10, 2015 AForm 4/A → | Sep 17, 8:36 am EDT | Jean F HollowayVP, General Counsel | 20,307 | — | — | 20,307 | — | |
| Sep 10, 2015 AForm 4/A → | Sep 17, 8:34 am EDT | William Robert MatthewsSenior VP, Operations, Quality | 8,000 | — | — | 8,000 | — | |
| Sep 10, 2015 AForm 4 → | Sep 17, 8:30 am EDT | John E DavisSenior VP, Global Sales | 10,000 | — | — | 10,000 | — | late |
| Sep 10, 2015 AForm 4 → | Sep 15, 7:02 am EDT | William Robert MatthewsSenior VP, Operations, Quality | 8,000 | — | — | 8,000 | — | late amended |
| Sep 10, 2015 AForm 4 → | Sep 14, 4:50 pm EDT | Jean F HollowayVP, General Counsel | 20,307 | — | — | 20,307 | — | amended |
| Apr 1, 2015 AForm 4 → | Apr 2, 5:00 pm EDT | Jean F HollowayVP, General Counsel | 7,000 | — | — | 7,000 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 8:36 am EST | Steven G AndersonExecutive Chairman | 63,750 | — | — | 0 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:55 pm EST | James P MackinPresident & CEO | 85,105 | — | — | 85,105 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:53 pm EST | David Ashley LeeExecutive VP, COO & CFO | 34,042 | — | — | 34,042 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:52 pm EST | David P. LangVP, Int'l Sales & Marketing | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:50 pm EST | Amy HortonChief Accounting Officer | 13,617 | — | — | 13,617 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:49 pm EST | David C GaleVP, Research & Development | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:47 pm EST | David FronkVP, Regulatory Affairs | 23,829 | — | — | 23,829 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:46 pm EST | Scott B CappsVP, Clinical Research | 20,425 | — | — | 20,425 | — | |
| Feb 19, 2015 AForm 4 → | Feb 20, 4:43 pm EST | Bruce G. AndersonVP, US Sales &Global Marketing | 20,425 | — | — | 20,425 | — | |
| Feb 16, 2015 MForm 4 → | Feb 25, 8:33 am EST | David FronkVP, Regulatory Affairs | 15,000 | — | — | 0 | — | late |